109 related articles for article (PubMed ID: 1963585)
1. Epstein-Barr virus terminal protein gene transcription is dependent on EBNA2 expression and provides evidence for viral integration into the host genome.
Zimber-Strobl U; Suentzenich K; Falk M; Laux G; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
Curr Top Microbiol Immunol; 1990; 166():359-66. PubMed ID: 1963585
[No Abstract] [Full Text] [Related]
2. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus gene expression during primary B-lymphocyte infection, in transformed and Burkitt lymphoma-derived cell lines.
Ernberg I; Kallin B; Dillner J
Curr Top Microbiol Immunol; 1986; 132():251-6. PubMed ID: 3024918
[No Abstract] [Full Text] [Related]
4. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.
Kempkes B; Zimber-Strobl U; Eissner G; Pawlita M; Falk M; Hammerschmidt W; Bornkamm GW
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():227-37. PubMed ID: 8627226
[TBL] [Abstract][Full Text] [Related]
5. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
6. A second nuclear protein is encoded by Epstein-Barr virus in latent infection.
Hennessy K; Kieff E
Science; 1985 Mar; 227(4691):1238-40. PubMed ID: 2983420
[TBL] [Abstract][Full Text] [Related]
7. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
8. Transformation-associated Epstein-Barr virus antigens as targets for immune attack.
Masucci MG; Gavioli R; de Campos-Lima PO; Zhang QJ; Trivedi P; Dolcetti R
Ann N Y Acad Sci; 1993 Aug; 690():86-100. PubMed ID: 7690218
[No Abstract] [Full Text] [Related]
9. Effect of TGF-beta on the proliferation of B cell lines and on the immortalisation of B cells by EBV.
Altiok A; Bejarano MT; Klein E
Curr Top Microbiol Immunol; 1990; 166():375-80. PubMed ID: 1963587
[No Abstract] [Full Text] [Related]
10. Epstein-Barr virus nuclear antigens 1 and 2 in Burkitt lymphoma cell lines containing either 'A'- or 'B'-type virus.
Sculley TB; Sculley DG; Pope JH; Bornkamm GW; Lenoir GM; Rickinson AB
Intervirology; 1988; 29(2):77-85. PubMed ID: 2842274
[TBL] [Abstract][Full Text] [Related]
11. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.
Dambaugh T; Wang F; Hennessy K; Woodland E; Rickinson A; Kieff E
J Virol; 1986 Aug; 59(2):453-62. PubMed ID: 2426468
[TBL] [Abstract][Full Text] [Related]
13. Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalization.
Mühe J; Wang F
PLoS Pathog; 2017 Dec; 13(12):e1006772. PubMed ID: 29261800
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) on B-Lymphocytic Activity.
Qu M; Ding F; Di S; Zhang S; Yu X
Clin Lab; 2018 Apr; 64(4):425-431. PubMed ID: 29739075
[TBL] [Abstract][Full Text] [Related]
15. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
Peng M; Lundgren E
Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
[TBL] [Abstract][Full Text] [Related]
17. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
[TBL] [Abstract][Full Text] [Related]
18. EBNA2 and Its Coactivator EBNA-LP.
Kempkes B; Ling PD
Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
[TBL] [Abstract][Full Text] [Related]
19. [Expression of latent membrane proteins (LMP) of Epstein-Barr virus in malignant lymphomas].
Herbst H; Dallenbach F; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Jautzke G; Müller-Lantzsch N; Stein H
Verh Dtsch Ges Pathol; 1991; 75():175-8. PubMed ID: 1724825
[TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
Peng R; Moses SC; Tan J; Kremmer E; Ling PD
J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]